96422 ⎘
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom Triazole or tetrazole radicals
GLYCOMIMETIC BINDERS FOR L-SIGN
#2GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR
#3BICYCLIC HETEROCYCLIC COMPOUNDS FOR PROPHYLAXIS ANDTREATMENT OF VIRAL INFECTIONS
#4NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#5THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME
#6AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME
#7BICYCLIC HETEROCYCLIC COMPOUNDS FOR PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS
#8NOVEL COMPOUND OR SALT THEREOF, AND ANTITUMOR ACTIVATOR CONTAINING SAME AS ACTIVE INGREDIENT
#9HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3
#10NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#11FLAVONE DERIVATIVE FOR TREATING TUMORS AND USE THEREOF
#12NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#13Galectin-3 inhibitors
#14Hyaluronan conjugate
#15Small molecule inhibitors of galectin-3
#16SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
#17GALACTOSE-LINKED MULTIMERIC GLYCOMIMETIC INHIBITORS OF E-SELECTINS, GALECTIN-3, AND/OR CXCR4 CHEMOKINE RECEPTORS
#18LARGE SCALE PROCESS
#19NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#20Galactoside inhibitor of galectins
#21(HETERO)ARYL-METHYL-THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES
#22(2-ACETAMIDYL)THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES
#23Galactoside inhibitor of galectins
#24CD73 INHIBITORS
#25NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
#26Synthesis of 3-azido-3-deoxy-D-galactopyranose
#27Small molecule inhibitors of galectin-3
#28Mannose derivatives for treating bacterial infections
#29Heterobifunctional inhibitors of E-selectin and galectin-3
#30Galectin-3 inhibiting c-glycosides
#31AMORPHOUS FORM OF 5-BROMOPYRIDIN-3-YL 3-DEOXY-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1-THIO-ALPHA-D-GALACTOPYRANOSIDE
#32Galactoside inhibitor of galectins
#33CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN
#34CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN
#35Therapeutic agents and methods of producing same
#36Uses of hyaluronan conjugate
#37GALACTOSIDE INHIBITOR OF GALECTINS
#38PRODRUG GALACTOSIDE INHIBITOR OF GALECTINS
#39Amyloid targeting agents and methods of using the same
#40SUGAR DERIVATIVE OR SALT THEREOF, AND ANTIBACTERIAL AGENT OR ANTIBACTERIAL ACTIVITY ENHANCER USING SAME
#41Galactoside inhibitor of galectins
#42Camptothecin derivatives and preparation methods and applications thereof
#43IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#44Compounds
#45CONJUGATES
#46CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#47MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#48Galactoside inhibitor of galectins
#49Immunogenic trehalose compounds and uses thereof
#50CD73 inhibitors
#51Galactoside inhibitor of galectins
#52Artemisinic acid glycoconjugate compounds, process for preparation and use thereof
#53Small molecule inhibitors of Galectin-3
#542,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#55Amyloid targeting agents and methods of using the same
#56Hybrid galactoside inhibitor of galectins
#57IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#58SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
#59Galactoside inhibitor of galectins
#60Alpha-D-galactoside inhibitors of galectins
#61Polymorphic forms and process
#62Compounds
#63Alpha-D-galactoside inhibitors of galectins
#64COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#65Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein
#66Polymorphic forms and process
#67Mannose derivatives for treating bacterial infections
#68Polymorphic forms and process
#69Synthesis process of precursors of derivatives of beta-lactam nuclei and precursors and derivatives thereof
#701,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectins
#71Amyloid targeting agents and methods of using the same
#72GLUCOPYRANOSIDE COMPOUND
#73MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#74Oligonucleotide derivative, oligonucleotide construct using the same, and methods for producing them
#75Conjugated antisense compounds and their use
#76Hybrid galactoside inhibitor of galectins
#77Galactoside inhibitor of galectins
#78Galactoside inhibitor of galectins
#79IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#80Compounds and methods for treating bacterial infections
#81MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#82Amyloid targeting agents and methods of using the same
#83AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS
#84Mannose derivatives for treating bacterial infections
#851,2,3-triazole-tethered carbohydrate-di and tri lipidated cysteine conjugates useful as vaccine adjuvants and process for preparation thereof
#86Water soluble polyfluorene functionalized with glucuronic acid useful in bilirubin sensing
#87GLUCOPYRANOSIDE COMPOUND
#88Galactoside inhibitor of galectins
#89STABILIZED NUCLEOTIDES FOR MEDICAL TREATMENT
#90Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#91Bridged-cyclo-ProTides as prodrugs of therapeutic nucleosides and nucleotides
#92Compounds and methods for treating bacterial infections
#93Azido nucleosides and nucleotide analogs
#94Antiviral phosphonate analogs
#95Sialic acid dimers
#96Anionic conjugates of glycosylated bacterial metabolite
#97Oligomer conjugates of heteropentacyclic nucleosides
#98Mannose derivatives for treating bacterial infections
#99Purine nucleoside analogues for treating flaviviridae including hepatitis C
#100MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#101Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same
#102Galactoside inhibitor of galectins
#103NOVEL SYNTHESIS OF GALACTOSIDE INHIBITORS
#104Antiviral phosphonate analogs
#105Dendritic starch-based dextrin adhesives
#106QUINOLINE DERIVATIVES USED AS PET IMAGING AGENTS
#107Compounds and methods for treating bacterial infections
#108Sialochimeric compounds
#109Glucopyranoside compound
#110Galactoside inhibitors of galectins
#1112-fluorinated riboses and arabinoses and methods of use and synthesis
#112Azido nucleosides and nucleotide analogs
#113ANTIVIRAL PHOSPHONATE ANALOGS
#114Anionic conjugates of glycosylated bacterial metabolite
#115Triazole derivatives, their preparation and their application in therapeutics
#116Synthesis of galactoside inhibitors
#117Nucleoside Phosphonate Analogs
#118Oligomer conjugates of heteropentacyclic nucleosides
#119MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#120ANTIVIRAL COMPOUNDS
#121Combinatorial production of nucleotide and nucleoside (XiTP) analogues
#122TRIAZOLE-BASED AMINOGLYCOSIDE-PEPTIDE CONJUGATES AND METHODS OF USE
#123PROTECTED NUCLEOTIDE ANALOGS
#124SYNTHESIS OF NOVEL XYLOSIDES AND POTENTIAL USES THEREOF
#125AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES
#126METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS
#127Antiviral compounds
#128Antiviral phosphonate analogs
#129PROTECTED NUCLEOTIDE ANALOGS
#130NUCLEOSIDE ANALOGS WITH CARBOXAMIDINE MODIFIED MONOCYCLIC BASE
#131Purine nucleoside analogues for treating including hepatitis C
#132DEUTERIUM-ENRICHED VIRAMIDINE
#133Heterobifunctional compounds for selectin inhibition
#1343-triazolyl-galactoside inhibitors of galectins
#135Modified 2′ and 3′-nucleoside prodrugs for treating infections
#136Modified 2′ and 3′-nucleoside prodrugs for treating infections
#137Modified 2′ and 3′-nucleoside prodrugs for treating infections
#138Modified 2′ and 3′-nucleoside prodrugs for treating infections
#139Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
#140Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
#141Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#142Modified 2′ and 3′-nucleoside prodrugs for treating infections
#143Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#144Multidrug resistant anticancer anthracyclines
#145Click chemistry method for synthesizing molecular imaging probes
#146Nucleoside phosphonate analogs
#147Antiviral phosphonate analogs
#148Nucleoside analogs with carboxamidine modified monocyclic base
#149Polymorphic antiviral nucleoside compounds
#150Triazole linked carbohydrates
#151Process for preparing antiviral nucleoside derivatives
#152Purine nucleoside analogues for treating Flaviviridae including hepatitis C
#153Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection